COVID-19 UPDATE: Firm Operations Continue Uninterrupted. Free Virtual Consultations Available. Click Here.
ACCIDENT NEWS

1 Killed, 1 Injured in Crash at Highway 180 and Academy Avenue


Pickup, Sedan Collide in Fatal Sanger Accident

Sanger, CA (July 15, 2020) – One person was killed and another was injured in a crash in Sanger. The fatal accident occurred on the evening of July 15 at Highway 180 and Academy Avenue.

A Honda Civic was traveling northbound on Academy Avenue when it collided with a Nissan pickup at the intersection. The driver of the Honda died at the accident scene. The driver of the Nissan was injured and taken to a local hospital. 

Our heartfelt condolences go out to the friends and loved ones of the victim. 

#Sanger

#93657


May 7, 2020

Catalina Esteves Killed in Crash on Gilman Springs Road

Jose Angel Perez Arrested for DUI in Fatal Accident...


March 20, 2020

Anthony Choza Killed in Crash at Hughes and Weber Avenues

Victim Hit by Car in Fatal Fresno Accident...


July 13, 2020

Woman Killed in Crash at Carolyn Weston Boulevard and Manthey Road

Solo-Vehicle Accident in Stockton Leads to Fatality...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


September 21, 2020

Lawsuit: ‘Tens Of Thousands’ Of Elmiron Patients At Risk For Vision Loss

A lawsuit filed on September 8 claims that “tens of thousands” of Elmiron patients were put at risk and hurt as a result of Janssen Pharmaceuticals’ conduct.


September 21, 2020

Lawsuit Claims Gilead Made ‘Unlawful’ Payment Over Truvada Competition

A lawsuit filed on Thursday claims that Gilead made an “unlawful” payment to Cipla in exchange for Cipla’s agreement to not compete against Truvada. The complaint states the payment “likely” came in the form of a license to produce Atripla, a license to produce Hepatitis C drugs in India or both.